WallStreetZenWallStreetZen

NASDAQ: MTEM
Molecular Templates Inc Earnings & Revenue

MTEM past revenue growth

How has MTEM's revenue growth performed historically?
Company
-33.68%
Industry
83.69%
Market
19.3%
MTEM's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MTEM's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MTEM's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MTEM earnings and revenue history

Current Revenue
$31.8M
Current Earnings
-$18.4M
Current Profit Margin
-57.9%

MTEM Return on Equity

Current Company
-896.9%
Current Industry
16.9%
Current Market
28.2%
MTEM's Return on Equity (-896.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MTEM announces earnings.

MTEM Return on Assets

Current Company
-51.8%
Current Industry
3.2%
MTEM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MTEM Return on Capital Employed

Current Company
-92.34%
Current Industry
-42.5%
MTEM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MTEM vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MTEM$31.76M-$11.28M-$18.40M+9.90%N/A
TRVN$3.14M-$35.78M-$40.15M-11.35%N/A
CVKD$0.00-$4.84M-$4.85MN/AN/A
PYPD$0.00-$21.05M-$23.87MN/A+28.76%
CHRO$0.00-$7.88M-$8.98MN/AN/A

MTEM earnings dates

Next earnings date
Aug 8, 2024

Molecular Templates Earnings & Revenue FAQ

What were MTEM's earnings last quarter?

On Invalid Date, Molecular Templates (NASDAQ: MTEM) reported Q1 2024 earnings per share (EPS) of $0.11, up 96.19% year over year. Total Molecular Templates earnings for the quarter were $572.00 thousand. In the same quarter last year, Molecular Templates's earnings per share (EPS) was $2.89.

If you're new to stock investing, here's how to buy Molecular Templates stock.

What was MTEM's earnings growth in the past year?

As of Q2 2024, Molecular Templates's earnings has grown year over year. Molecular Templates's earnings in the past year totalled -$18.40 million.

What is MTEM's earnings date?

Molecular Templates's earnings date is Invalid Date. Add MTEM to your watchlist to be reminded of MTEM's next earnings announcement.

What was MTEM's revenue last quarter?

On Invalid Date, Molecular Templates (NASDAQ: MTEM) reported Q1 2024 revenue of $11.09 million up 69.73% year over year. In the same quarter last year, Molecular Templates's revenue was $36.63 million.

What was MTEM's revenue growth in the past year?

As of Q2 2024, Molecular Templates's revenue has grown -33.68% year over year. This is 117.37 percentage points lower than the US Biotechnology industry revenue growth rate of 83.69%. Molecular Templates's revenue in the past year totalled $31.76 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.